Wolverine Trading’s Intersect ENT, Inc XENT Stock Holding History

Wolverine Trading’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-18,400	Closed	-$236K	–	5404
2020 Q2	$236K	Buy	18,400 +7,600	+70%	+$88.4K	﹤0.01%	3632
2020 Q1	$126K	Buy	+10,800	New	+$239K	﹤0.01%	3918
2019 Q3	–	Sell	-11,100	Closed	-$253K	–	5253
2019 Q2	$253K	Sell	11,100 -5,300	-32%	-$143K	﹤0.01%	3460
2019 Q1	$527K	Buy	+16,400	New	+$507K	﹤0.01%	2716
2018 Q4	–	Sell	-20,500	Closed	-$589K	–	5645
2018 Q3	$589K	Buy	+20,500	New	+$616K	﹤0.01%	2916

Other funds holding XENT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wolverine Trading's XENT Position: Q2 2020 in Review

Wolverine Trading sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 11,016 shares — an estimated $128K sold.

Wolverine Trading first reported a position in XENT in Q1 2017 and held it in 5 quarters. The position peaked at $341K in Q4 2017. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

Wolverine Trading reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
Wolverine Trading sold 11,016 Intersect ENT, Inc shares in Q2 2020, an estimated $128K.
Wolverine Trading first reported a position in Intersect ENT, Inc in Q1 2017 and held it in 5 quarters.
Wolverine Trading's Intersect ENT, Inc position peaked at $341K in Q4 2017.
108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.